D. Gray Heppner, Jr.

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.

V. A. Stewart, W. Ballou, Joe D. Cohen, 2009, The Journal of infectious diseases.

Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccine.

W. Ballou, O. Ofori-Anyinam, C. Ockenhouse, 2010, The Journal of infectious diseases.